PBRM1 and nonpapillary renal cell carcinoma: As suggested by previous molecular analysis of early stage ccRCC, although mutations in PBRM1 are frequent, they may not differentiate aggressive versus non-aggressive tumors as much as represent an early, potentially essential event in tumorigenesis that does not impact significantly clinical outcome21.